HEPATITIS D

 

HEPATITIS D

 

DEFINITION:

An infectious disease of the liver caused by the hepatitis D virus (HDV) resulting in an acute and chronic hepatitis.

EPIDEMIOLOGY:

  • incidence: ?
  • age of onset:
    • ?
  • risk factors:
    • IV drug users, hemophiliacs, institutionalized mentally retarded patients (but not homosexuals)
    • epidemics of superinfection have been reported in South America

PATHOGENESIS:

1. Etiology

1. Hepatitis D Virus

  • a single-stranded circular RNA satellite virus 35 nm in diameter
  • a double-shelled particle with an external coat composed of Hepatitis B surface antigen (HBsAg) provided by the helper Hepatitis B virus (HBV) genome and an internal coat composed of delta antigen provided by the HDV genome - thought of as a defective RNA virus that can replicate only in the presence of an acute or chronic HBV infection - routes of infection:
    • usually parenteral
    • occasionally through intimate sexual contact
    • perinatal infection is rare

2. Hepatitis D

  • occurs with two types of HBV infection:

1. Coinfection

  • simultaneous onset of acute HBV & HDV infection

2. Superinfection

  • a chronic HBV carrier is infected with HDV

2. Pathogenesis

  • infection -> 21-90 day incubation period -> hepatocellular damage (elevated ALT) -> hepatitis -> HBsAg is cleared and HDV replication ceases -> acute liver disease resolves

CLINICAL FEATURES:

1. Prodrome

  • arthritis and rash may be present

2. Hepatitis

  • acute onset with duration of illness ranging from several weeks to months
  • while the preicteric phase can last up to 5 days, the icteric phase lasts from days to months with a mean of 8-11 days in children

1. Preicteric Phase

1. Fever

  • may be absent in children but last up to 5 days in adolescents
  • ranges from 37.8-40 C

2. Accompanying Signs/Symptoms

  • abdominal pain
  • anorexia
  • headache
  • lethargy
  • nausea/vomiting
  • hepatomegaly (tender)
  • lymphadenopathy
  • splenomegaly

2. Icteric Phase

1. Jaundice

  • is a component of coinfection but not superinfection
  • transition to the icteric phase is marked by the disappearance of preicteric signs/symptoms in young children but the exacerbation of these signs/symptoms in older children and adolescents
  • accompanied by dark urine (biliuria) +/- clay-coloured stools
  • may be anicteric in infants and children less than 3 years of age

3. Hepatic Complications

1. Chronic Persistent Hepatitis

  • a pathological diagnosis based on finding an inflammatory process on liver biopsy involving only the portal areas - anicteric and asymptomatic except for mild hepatomegaly
  • moderate elevation of ALT
  • lasts longer than 6 months and may resolve after years or progress to chronic active hepatitis

2. Chronic Active Hepatitis

  • chronic and recurrent episodes of jaundice and elevated
  • ALT and AST
  • may progress to cirrhosis +/- portal hypertension with ascites

3. Liver Failure

1. Fulminant Hepatitis

  • liver failure occurring within days to 4 weeks after onset of acute hepatitis
  • associated with mental confusion, emotional instability, restlessness, bleeding, and coma
  • those patients with superinfection are at greatest risk for development of fulminant hepatitis

2. Subacute Hepatitis

  • liver failure occurring 1-3 months after the onset of acute hepatitis

INVESTIGATIONS:

1. Coinfection

1. Serum

1. Alanine Aminotransferase (ALT)

  • striking rise in level after the incubation period, is biphasic, and can last up to 3 months

2. Bilirubin

  • transient elevation associated with the peak in ALT levels lasting for about 1 month

3. Serology

  • anti-HDV is detected at the onset of signs/symptoms and is initially predominantly IgM but then later is exclusively IgG (after 12 months)
  • the high levels of IgG do not persist but are transient
  • anti-HBs begins to rise after 6 months

4. Viremia

  • HBsAg appears during the latter part of the incubation period followed by HDV RNA and last 3.5 and 2 months, respectively

2. Superinfection

1. Serum

1. Alanine Aminotransferase (ALT)

  • striking rise in level after the incubation period and persists

2. Bilirubin

  • there does not appear to be an elevation in bilirubin levels

3. Serology

  • anti-HDV responds the same way as with the coinfection except that high levels of the IgG persist
  • there is no rise in anti-HBs

4. Viremia

  • HBsAg is present before superinfection and persists
  • HDV RNA appears during the signs/symptoms and persists

MANAGEMENT:

1. Supportive

  • symptomatic

2. Prognosis

  • can result in chronic hepatitis, liver disease, and/or a carrier state (yet there is a very low risk of perinatal infection)
  • mortality from a fulminant hepatitis is:
    • 2-20% with coinfection
    • up to 30% with superinfection

 

 

Pediatric Database - HEPATITIS D

Pediatric Organization - Pedbase [at] Gmail.com